KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,202,000 | -79.4% | 120,480 | -73.7% | 0.01% | -79.6% |
| Q1 2015 | $5,825,000 | +17.5% | 457,622 | +30.6% | 0.05% | +14.0% |
| Q4 2014 | $4,959,000 | +11.3% | 350,514 | +8.1% | 0.04% | +4.9% |
| Q3 2014 | $4,457,000 | -7.8% | 324,155 | +3.1% | 0.04% | -6.8% |
| Q2 2014 | $4,834,000 | +88.5% | 314,287 | +108.8% | 0.04% | +22.2% |
| Q1 2014 | $2,565,000 | +816.1% | 150,526 | +597.0% | 0.04% | +800.0% |
| Q4 2013 | $280,000 | – | 21,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
| Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
| 1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
| Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
| FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
| OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
| Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
| Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
| THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |